Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors. - Wikidata - wikimedia - TriplyDB

Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.

Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.

http://www.wikidata.org/entity/Q35111983

about

Mechanisms of Oncolysis by Paramyxovirus Sendai Oncolysis by paramyxoviruses: preclinical and clinical studies.Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Viral and Synthetic RNA Vector Technologies and Applications.

P2860

Q35721486-74B71ACD-6291-41D6-8894-BF72379FE0A1 Q35861933-32A5597A-6F78-4AA0-B7D5-BF70A0FDA775 Q35861936-41A1BAA8-DB75-4CCA-8FC0-8604A09EC54F Q38885624-F9D2874F-F63F-49B1-9A59-49A2311C22A2

P2860

Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.

http://www.wikidata.org/entity/Q35111983

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Attenuated and protease-profil ...... r virotherapy of solid tumors.

@ast

Attenuated and protease-profil ...... r virotherapy of solid tumors.

@en

type

label

Attenuated and protease-profil ...... r virotherapy of solid tumors.

@ast

Attenuated and protease-profil ...... r virotherapy of solid tumors.

@en

prefLabel

Attenuated and protease-profil ...... r virotherapy of solid tumors.

@ast

Attenuated and protease-profil ...... r virotherapy of solid tumors.

@en

P1433

Q35111983-CFE2E458-D268-4EE9-A49B-19FB7A36BD2F

P1476

Q35111983-5CEA3F8D-1920-4643-A36B-096D2A79CB3F

P2093

Q35111983-1A262A05-FA53-4C04-A43F-EF2D944F078B

Q35111983-4EC95D57-F6CD-4FD6-96B5-13744658F0FB

Q35111983-8DB361E9-3D92-4864-8235-96CBCF147AC4

Q35111983-B0C05BF1-4B40-4E5C-BE09-B81DCD0BF2A0

Q35111983-B2540611-37A0-49A4-924A-3319EA09B6F2

Q35111983-B43B04E5-7A4D-462E-9497-FA0FAFF2FF07

Q35111983-BED4F882-3F8C-4575-8A28-2F7A3ECCD961

Q35111983-C049393F-F28F-4E31-A7CB-8FD986E4E909

Q35111983-FE4567CA-63C4-4B47-86D7-8F8D21FC165C

P2860

Q35111983-0008294F-0ADB-470C-BC0F-EEBDBF03452C

Q35111983-01192ABC-CADB-4D8B-8700-5EE1CEE60818

Q35111983-0133451A-9CAA-4633-AA9C-BE299A558AB8

Q35111983-042B2328-B13D-4A4A-8C83-4195517E1132

Q35111983-0617E072-2745-42CA-9D95-732B17B5E27F

Q35111983-081D3168-0B7A-4457-823F-41860BAF61E7

Q35111983-09389389-5B01-4971-8D31-AB02CBB3AA7F

Q35111983-0CAEEE15-D4EB-4016-BBEB-CE9CC0F427C8

Q35111983-192BB9CB-F75B-4AA2-B92F-04B34F5A9E4B

Q35111983-19CD87B3-CD0C-48CB-87EB-3CACDE62E222

P304

Q35111983-594B1DC2-4EF8-497E-94F0-C354A670FA62

P31

Q35111983-14F75646-91F6-4F3F-9BD2-F188BE070CF8

P356

Q35111983-F181AC2B-07A0-4E69-8B74-CB24DD1BEB30

P407

Q35111983-D8DFF425-5D9B-432B-AF81-058F2FF0340F

P433

Q35111983-8B27F809-7766-4B0D-B423-397385EED698

P478

Q35111983-0481712A-6E17-4E52-8E00-326987E53B0B

P50

Q35111983-0C692567-5ED3-452C-9C03-6EC749948D42

Q35111983-8438A9DE-9121-4590-931A-EFC922655864

P577

Q35111983-EAF2ED00-0D65-4075-B356-273D025EC3B2

P5875

Q35111983-16719DA5-3A5B-46E1-90AA-C17D8DA528DA

P698

Q35111983-1CD1800B-4312-40CD-8D92-C19C4B6A2AFB

P921

Q35111983-6FECF201-DC91-497C-89EF-C76C26CA3257

Q35111983-9B22C970-5C65-477B-8C0B-FE149C5CFD72

P932

Q35111983-8DFA955E-8BC5-4E8C-8ADB-FDCA82020F0F

P356

JOURNAL.PONE.0090508

P1433

P1476

Attenuated and protease-profil ...... r virotherapy of solid tumors.

@en

P2093

Andrea Schenk

http://www.w3.org/2001/XMLSchema#string

Irina Smirnow

http://www.w3.org/2001/XMLSchema#string

Johanna Lampe

http://www.w3.org/2001/XMLSchema#string

Martina Zimmermann

http://www.w3.org/2001/XMLSchema#string

Michael Bitzer

http://www.w3.org/2001/XMLSchema#string

Sascha Bossow

http://www.w3.org/2001/XMLSchema#string

Sorin Armeanu-Ebinger

http://www.w3.org/2001/XMLSchema#string

Ulrich M Lauer

http://www.w3.org/2001/XMLSchema#string

Wolfgang Neubert

http://www.w3.org/2001/XMLSchema#string

P2860

New colorimetric cytotoxicity assay for anticancer-drug screening

A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization.

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection.

Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene.

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer.

P304

e90508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0090508

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Sebastian Lange

P577

2014-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260562455

http://www.w3.org/2001/XMLSchema#string

P698

24598703

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

3944018

http://www.w3.org/2001/XMLSchema#string